Abbott Laboratories (NYSE:ABT)

70.76
Delayed Data
As of Dec 14
 -1.42 / -1.97%
Today’s Change
54.63
Today|||52-Week Range
74.92
+23.99%
Year-to-Date

Today’s Trading

Previous close72.18
Today’s open71.32
Day’s range70.37 - 71.50
Volume5,670,292
Average volume (3 months)6,281,843
Market cap$120.4B
Data as of 4:01pm ET, 12/14/2018

Growth & Valuation

Earnings growth (last year)-71.15%
Earnings growth (this year)+15.38%
Earnings growth (next 5 years)+11.95%
Revenue growth (last year)+31.35%
P/E ratio157.2
Price/Sales3.64
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-2.93-2.55%
SNYSanofi-0.84-1.87%
ABBVAbbVie-2.10-2.39%
AZNAstraZeneca-0.09-0.23%
Data as of 4:02pm ET, 12/14/2018

Financials

Next reporting dateJanuary 23, 2019
EPS forecast (this quarter)$0.81
Annual revenue (last year)$27.4B
Annual profit (last year)$468.0M
Net profit margin1.26%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
President &
Chief Operating Officer
Robert B. Ford
Corporate headquarters
Abbott Park, Illinois

Forecasts